Literature DB >> 22923228

Implantable electrophysiologic cardiac device infections: a risk factor analysis.

D Raad1, J Irani, E G Akl, S Choueiri, E Azar, J Abboud, C Afif.   

Abstract

The risk of cardiac device infection (CDI) is rising significantly, with several risk factors identified. The purpose of this study is to determine the rate of CDI at our center and to assess the associated risk factors, in order to define appropriate measures to prevent this complication. We retrospectively reviewed all cases of patients with CDI at St. George Hospital between February 1999 and July 2010. Each case was matched with three controls. We performed a descriptive and bivariate analysis to identify significant risk factors. Eighteen case patients and 54 control subjects met the inclusion criteria. An organism was recovered in 58 % of the cases. Significant risk factors included previous history of CDI (p < 0.001), recent manipulation (p < 0.001), trauma to the site of implant (p = 0.003), having a dual chamber/dual lead pacemaker (p = 0.002), and development of post-procedural hematoma (p = 0.012). Our findings complement the results of previous studies. We recommend a pre-procedural risk assessment and a thorough post-implantation follow-up to prevent the development of infective complications.

Entities:  

Mesh:

Year:  2012        PMID: 22923228     DOI: 10.1007/s10096-012-1655-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories.

Authors:  Paul A Gould; Andrew D Krahn
Journal:  JAMA       Date:  2006-04-26       Impact factor: 56.272

Review 2.  Clinical competency statement: Training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices.

Authors:  Anne B Curtis; Kenneth A Ellenbogen; Stephen C Hammill; David L Hayes; Dwight W Reynolds; David J Wilber; Michael E Cain
Journal:  Heart Rhythm       Date:  2004-09       Impact factor: 6.343

3.  16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008.

Authors:  Arnold J Greenspon; Jasmine D Patel; Edmund Lau; Jorge A Ochoa; Daniel R Frisch; Reginald T Ho; Behzad B Pavri; Steven M Kurtz
Journal:  J Am Coll Cardiol       Date:  2011-08-30       Impact factor: 24.094

4.  Mortality and cost associated with cardiovascular implantable electronic device infections.

Authors:  Muhammad R Sohail; Charles A Henrikson; Mary Jo Braid-Forbes; Kevin F Forbes; Daniel J Lerner
Journal:  Arch Intern Med       Date:  2011-09-12

5.  The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries.

Authors:  Sana M Al-Khatib; F Lee Lucas; James G Jollis; David J Malenka; David E Wennberg
Journal:  J Am Coll Cardiol       Date:  2005-09-23       Impact factor: 24.094

6.  Diagnosis and management of infections involving implantable electrophysiologic cardiac devices.

Authors:  J D Chua; B L Wilkoff; I Lee; N Juratli; D L Longworth; S M Gordon
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

7.  Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy.

Authors:  Uwe K H Wiegand; Dominik LeJeune; Frank Boguschewski; Hendrik Bonnemeier; Frank Eberhardt; Heribert Schunkert; Frank Bode
Journal:  Chest       Date:  2004-10       Impact factor: 9.410

8.  New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service.

Authors:  D T Durack; A S Lukes; D K Bright
Journal:  Am J Med       Date:  1994-03       Impact factor: 4.965

9.  Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery.

Authors:  Heather Bloom; Brian Heeke; Angel Leon; Fernando Mera; David Delurgio; John Beshai; Jonathan Langberg
Journal:  Pacing Clin Electrophysiol       Date:  2006-02       Impact factor: 1.976

10.  Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences.

Authors:  Pablo B Nery; Russell Fernandes; Girish M Nair; Glen L Sumner; Carlos S Ribas; Syamkumar M Divakara Menon; Xiaoyin Wang; Andrew D Krahn; Carlos A Morillo; Stuart J Connolly; Jeff S Healey
Journal:  J Cardiovasc Electrophysiol       Date:  2010-01-22
View more
  11 in total

1.  Association of Uninterrupted Oral Anticoagulation During Cardiac Device Implantation with Pocket Hematoma.

Authors:  Brittany L Melton; Patricia A Howard; Abby Goerdt; Jessica Casey
Journal:  Hosp Pharm       Date:  2015-10-14

2.  Utilization and in-hospital complications of cardiac resynchronization therapy: trends in the United States from 2003 to 2013.

Authors:  Seyed Mohammadreza Hosseini; Kasra Moazzami; Guy Rozen; Jeena Vaid; Ahmed Saleh; Kevin E Heist; Mark Vangel; Jeremy N Ruskin
Journal:  Eur Heart J       Date:  2017-07-14       Impact factor: 29.983

3.  Use of a pocket compression device for the prevention and treatment of pocket hematoma after pacemaker and defibrillator implantation (STOP-HEMATOMA-I).

Authors:  Mohit K Turagam; Darbhamulla V Nagarajan; Krzysztof Bartus; Akash Makkar; Vijay Swarup
Journal:  J Interv Card Electrophysiol       Date:  2017-04-17       Impact factor: 1.900

4.  Epidemiology of cardiac implantable electronic device infections: incidence and risk factors.

Authors:  Hui-Chen Han; Nathaniel M Hawkins; Charles M Pearman; David H Birnie; Andrew D Krahn
Journal:  Europace       Date:  2021-06-23       Impact factor: 5.214

5.  Risk factors influencing complications of cardiac implantable electronic device implantation: infection, pneumothorax and heart perforation: a nationwide population-based cohort study.

Authors:  Yu-Sheng Lin; Sheng-Ping Hung; Pei-Rung Chen; Chia-Hung Yang; Hung-Ta Wo; Po-Cheng Chang; Chun-Chieh Wang; Chung-Chuan Chou; Ming-Shien Wen; Chang-Ming Chung; Tien-Hsing Chen
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

6.  Incidence of Bleeding-Related Complications During Primary Implantation and Replacement of Cardiac Implantable Electronic Devices.

Authors:  Christine I Nichols; Joshua G Vose
Journal:  J Am Heart Assoc       Date:  2017-01-22       Impact factor: 5.501

7.  Post procedural complications of cardiac implants done in a resource limited setting under 'C' arm: A single centre experience.

Authors:  A Jayachandra; Vivek Aggarwal; Sandeep Kumar; I V Nagesh
Journal:  Med J Armed Forces India       Date:  2017-12-09

8.  Postimplantation pocket hematoma increases risk of cardiac implantable electronic device infection: A meta-analysis.

Authors:  Jakrin Kewcharoen; Chanavuth Kanitsoraphan; Sittinun Thangjui; Thiratest Leesutipornchai; Sakditad Saowapa; Apichai Pokawattana; Leenhapong Navaravong
Journal:  J Arrhythm       Date:  2021-03-13

9.  A comprehensive multiscale framework for simulating optogenetics in the heart.

Authors:  Patrick M Boyle; John C Williams; Christina M Ambrosi; Emilia Entcheva; Natalia A Trayanova
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Impact of Chronic Kidney Disease on Short-Term Cardiac Implantable Electronic Device Related Infection: A Nationwide Population-Based Cohort Study.

Authors:  Yu-Sheng Lin; Tien-Hsing Chen; Ming-Shyan Lin; Dong Yi Chen; Chun-Tai Mao; Jen-Te Hsu; Huang-Chung Chen; Mien-Cheng Chen
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.